Journal ArticleDOI
Cardiovascular Health at the Crossroads: Outlook for the 21st Century Presented at the 67th Scientific Sessions of the American Heart Association November 4, 1994 Dallas, Texas
Reads0
Chats0
About:
This article is published in Circulation.The article was published on 1995-02-15. It has received 5 citations till now.read more
Citations
More filters
Journal ArticleDOI
Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice
TL;DR: In response to angiotensin II, cardiac fibroblasts proliferate through both the local and systemic action of Ang II, indicating that a communication between myocytes and fibro Blasts plays an important role during Ang II-dependent cardiac remodeling.
Journal ArticleDOI
International co-operation in world cardiology. The role of the World Heart Federation
TL;DR: The World Heart Federation is convinced that it now has a firm base from which to define the future role of the WorldHeart Federation in world cardiology, and hopes to increase even further the collaboration between professional organizations and national heart foundations within the Fed, which would benefit both the fund-raising and the scientific aims.
Journal ArticleDOI
International cooperation in world cardiology: the role of the World Heart Federation.
TL;DR: The fight against tobacco use is 1 important aim of the World Heart Federation, which brings together national societies of cardiology and heart foundations from 81 countries, as well as “continental” members covering the Asia-Pacific region, Europe, the Americas, and Africa.
Journal ArticleDOI
Cooperación internacional en la cardiología mundial: el papel de la World Heart Federation
Journal ArticleDOI
El futuro de la cardiología en España a partir de la evolución en los últimos 30 años
TL;DR: The frequency and trends of cardiovascular disease in Spain during the last 30 years, the socioeconomical changes in health care and the role of the cardiologist over the last decade are discussed, as a background for the challenges to be addressed as the year 2000 approaches.
References
More filters
Journal ArticleDOI
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
TL;DR: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Journal ArticleDOI
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. results of the survival and ventricular enlargement trial
Marc A. Pfeffer,Eugene Braunwald,Lemuel A. Moyé,Lofty L. Basta,Edward J. Brown,Thomas E. Cuddy,Barry R. Davis,Edward M. Geltman,Steven Goldman,Greg C. Flaker,Marc Klein,Gervasio A. Lamas,Milton Packer,Jacques R. Rouleau,Jean L. Rouleau,John D. Rutherford,John H. Wertheimer,C. Morton Hawkins +17 more
TL;DR: In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.
Journal ArticleDOI
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group
TL;DR: Captopril protects against deterioration in renal function in insulin-dependent diabetic nephropathy and is significantly more effective than blood-pressure control alone.
Journal ArticleDOI
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
Karl Swedberg,John Kjekshus +1 more
TL;DR: The addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms, and the effect seems to be due to a reduction in death from progression of heart failure.
Journal ArticleDOI
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.
TL;DR: The insertion/deletion polymorphism accounted for 47% of the total phenotypic variance of serum ACE, showing that the ACE gene locus is the major locus that determines serum ACE concentration.